The future of seamless implantable electrical interfaces

A new generation of implantable electrodes

Therapeutic outcomes from clinical neural implants are limited by their mechanical properties. Their stiff and rigid designs present a mechanical mismatch compared to the soft and curved tissues they interface with, thereby constraining the physiological motion dynamics of the nervous system.

 

At Neurosoft Bioelectronics, we are addressing this issue by engineering elasticity in thin film materials to manufacture implantable electrodes that are much softer and flexible, and that can seamlessly interface with the nervous system.

Latest News

Neurosoft Bioelectronics receives Catalyze4Life 2020 funding

Neurosoft Bioelectronics receives Catalyze4Life 2020 funding

Neurosoft Bioelectronics is thrilled and proud to announce that it was one of three projects selected for funding through the Catalyze4Life (C4L) competition, organized by EPFL’s School of Life Sciences to identify innovative research projects across EPFL. “The...

read more
Neurosoft wins 2020 Swiss Healthcare Startup competition!

Neurosoft wins 2020 Swiss Healthcare Startup competition!

We are one of the two startups selected to fly to the Silicon Valley in 2020! The competition started in October 2019 and confronted healthcare companies from all over Switzerland. A jury selected the 10 top startups who were split in two clusters. In the second...

read more

Supported by